BG
ATRS

BlackRock Group’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,246
Closed -$21K – 3054
2015
Q3 		$21K Buy
+12,246
New +$24K ﹤0.01% 2975
2015
Q1 		– Sell
-2,596
Closed -$7K – 2900
2014
Q4 		$7K Hold
2,596
– – ﹤0.01% 2860
2014
Q3 		$5K Hold
2,596
– – ﹤0.01% 2823
2014
Q2 		$7K Hold
2,596
– – ﹤0.01% 2805
2014
Q1 		$9K Hold
2,596
– – ﹤0.01% 2710
2013
Q4 		$12K Hold
2,596
– – ﹤0.01% 2619
2013
Q3 		$11K Hold
2,596
– – ﹤0.01% 2834
2013
Q2 		$11K Buy
+2,596
New +$10K ﹤0.01% 2554

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Group's ATRS Position: Q4 2015 in Review

BlackRock Group sold out of Antares Pharma, Inc. (ATRS) in Q4 2015, closing a stake of 12,246 shares — an estimated $21K sold.

BlackRock Group first reported a position in ATRS in Q2 2013 and held it in 8 quarters. The position peaked at $21K in Q3 2015. 88 funds tracked by Wall St. Rank hold ATRS as of Q4 2015.

  • BlackRock Group reported no remaining Antares Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • BlackRock Group sold 12,246 Antares Pharma, Inc. shares in Q4 2015, an estimated $21K.
  • BlackRock Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 8 quarters.
  • BlackRock Group's Antares Pharma, Inc. position peaked at $21K in Q3 2015.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2015.

Based on BlackRock Group's 13F filing for Q4 2015, filed 11 Feb 2016.